Enzon Pharma (ENZN) Ends Development of rhMBL, Announces Survivin Antagonist IND Accepted
Go back to Enzon Pharma (ENZN) Ends Development of rhMBL, Announces Survivin Antagonist IND Accepted| Enzon Pharmaceuticals, Inc. (AMEX: ENZN) | Delayed: 4.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.35 | 52 Week High | $1.10 | |||
| Open | $4.35 | 52 Week Low | $0.35 | |||
| Day High | $4.35 | P/E | 31.07 | |||
| Day Low | $4.35 | EPS | $0.14 | |||
| Volume | 1,283,665 | |||||
